Binding polypeptides for B lymphocyte stimulator protein (BLyS)

Details Binding polypeptides for B lymphocyte stimulator protein (BLyS) Binding polypeptides for B lymphocyte stimulator protein (BLyS)

2006-10-10

2006-10-10

Chism, B. Dell (Department: 1654)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C514S012200, C514S013800, C514S015800

Reexamination Certificate

active

07118872

ABSTRACT:
Binding polypeptides comprising specific amino acid sequences are disclosed that bind B Lymphocyte Stimulator (BLyS) protein or BLyS-like polypeptides. The binding polypeptides can be used in methods of the invention for detecting or isolating BLyS protein or BLyS-like polypeptides in solutions or mixtures, such as blood, tissue samples, or conditioned media.

REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5403484 (1995-04-01), Ladner et al.
patent: 5474981 (1995-12-01), Ladner et al.
patent: 5571698 (1996-11-01), Ladner et al.
patent: 5576195 (1996-11-01), Robinson et al.
patent: 5643575 (1997-07-01), Martinez et al.
patent: 5795724 (1998-08-01), Hillman et al.
patent: 5846818 (1998-12-01), Robinson et al.
patent: 5869331 (1999-02-01), Dornburg
patent: 6207160 (2001-03-01), Victoria et al.
patent: 6475981 (2002-11-01), Shu
patent: 2002/0081296 (2002-06-01), Theill et al.
patent: 439095 (1998-05-01), None
patent: WO 93/21232 (1993-10-01), None
patent: WO 97/46251 (1997-12-01), None
patent: WO 98/50547 (1998-11-01), None
patent: WO 00/43032 (2000-07-01), None
patent: WO 01/81417 (2001-11-01), None
patent: WO 02/24909 (2002-03-01), None
patent: WO 02/092620 (2002-11-01), None
patent: WO 02/094852 (2002-11-01), None
patent: WO 03/030833 (2003-04-01), None
Sauge-Merle et al., 1999, European Journal of Biochemistry, vol. 266, pp. 62-69.
Han et al., 1998, Virology, vol. 251, pp. 253-263.
Caliceti et al.,Bioconjug. Chem., 10:638-646 (1999).
Moore et al.,Science, 285: 260-263 (1999).
Morpurgo et al.,Appl. Biochem. Biotechnol., 56:59-72 (1996).
Vorobjev et al.,Nucleosides&Nucleotides, 18: 2745-2750 (1999).
Koo et al.,FEMS Microbiology Letters, 134: 159-164 (1995).
Malvar et al.,Genetics, 132: 951-962 (1992).
Vandenberghe et al.,Biochemistry, 37(8): 13075-13081 (1998).
Xia et al.,J. Experimental Medicine, 192(1): 137-143 (2000).
Yan et al.,Nature Immunology, 1(1): 37-41 (2000).
U.S. Appl. No. 09/932,613, filed Aug. 17, 2001, Beltzer et al.
U.S. Appl. No. 60/132,892, filed Jan. 2002, Shu.
U.S. Appl. No. 60/201,012, filed Jan. 2002, Shu.
U.S. Appl. No. 60/204,039, filed Jan. 2002, Theill.
U.S. Appl. No. 60/214,591, filed Jan. 2002, Theill.
Cull et al.,Proc. Natl. Acad. Sci. USA, “Screening for receptor ligands using large libraries of peptides linked to the C terminus of thelacrepressor”, vol. 89: pp. 1865-1869 (1992).
Cwirla et al.,Proc. Natl. Acad. Sci. USA,“Peptides on phage: A vast library of peptides for identifying ligands”, vol. 87: pp. 6378-6382 (1990).
Devlin,Science, “Random Peptide Libraries: A Source of Specific Protein Binding Molecules”, vol. 249: pp. 404-406 (1990).
Fell et al.,J. Immunol., “Genetic Construction and Characterization of a Fusion Protein Consisting of a Chimeric F(ab') with Specificity for Carcinomas and Human IL-2”, vol. 246: pp. 2446/2452 (1991).
Felici,J.Mol.Bio., “Selection of Antibody Ligands from a Large Library of Oligopeptides Expressed on a Mulivalent Exposition Vector”, vol. 222: pp. 301-310 (1991).
Fodor,Nature, “Multiplexed biochemical assays with biological chips”, vol. 364: pp. 555-556 (1993).
Gillies et al.,Proc. Natl. Acad. Sci. USA, “Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells”, vol. 89: pp. 1428-1432 (1992).
Hahne et al.J.Exp. Med., “APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth”, vol. 188(6): pp. 1185-1190 (1998).
Houghten,Bio/Techniques,“The Use of Synthetic Peptide Combinatorial Libraries for the Identification of Bioactive Peptides”, vol. 13: pp. 412-411 (1992).
Kwon et al.,J.Biol. Chem., “Identification of a Novel Activation-inducible Protein of the Tumor Necrosis Factor Receptor Superfamily and It's Ligand”, vol. 274(10): pp. 6056-6061 (1999).
Lam,Nature, “A new type of synthetic peptide library for identifying ligand-binding activity”, vol. 354: pp. 82-84 (1991).
Mauri et al.,Immunity, “LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator”, vol. 8(1), pp. 21-30 (1998).
Moore et al.,Science, “BLys: Member of the Tumor Necrosis Factor Family and B Lymphocyte Stimulator”, vol. 285: pp. 260-263 (1999).
Naramura et al.,Immunol. Lett.,“Mechanisms of cellular cytotoxicity mediated by a recombinant antibody-IL2 fusion protein against human melanoma cells”, vol. 39: pp. 91-99 (1994).
Nedwin et al.,J. Immunol., “Effect of Interleukin 2, Interferon-γ, and Mitogens on the Production of Tumor Necrosis Factors α and β”, vol. 135(4), pp. 2492-2497 (1985).
Scott and Smith,Science, “Searching for Peptide Ligands with an Epitope Library”, vol. 249: pp. 386-390 (1990).
Suda et al.,Cell, “Molecular Cloning and Expression of the Fas Ligand, a Novel Member of the Tumor Necrosis Factor Family”, vol. 75(6): pp. 1169-1178 (1993).
Von Bulow and Brann,Science, “NF-AT Activation Induced by a CAML-Interacting Member of Tumor Necrosis Factor Receptor Superfamily”, vol. 278: pp. 138-141 (1997).
Wiley et al.,Immunity,“Identification and Characterization of a New Member of the TNF Family that Induces Apoptosis”, vol. 3(6): pp. 673-682 (1995).
Durner et al.,Arthritis Res.,“B cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus”, vol. 3: pp. 197-199 (2001).
Xia et al.,J. Exp., “Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity”, vol. 192(1): pp. 137-143 (2000).
Gross et al.,Nature,“TACI Is a TRAF-interacting Receptor for TALL-1, a Tumor Necrosis Factor Family Member Involved in B Cell Regulation”, vol. 404: pp. 995-999 (2000).
Yan et al.,Nature Immunology,“TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease”, vol. 1(1): pp. 37-41 (2000).
European Patent Office Communication pursuant to Article 96(2) EPC, dated Sep. 9, 2005.

Affiliated with

Also associated with

Rating

Binding polypeptides for B lymphocyte stimulator protein (BLyS) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Binding polypeptides for B lymphocyte stimulator protein (BLyS), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Binding polypeptides for B lymphocyte stimulator protein (BLyS) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3718960